Live Terminal | Security Analysis of RGEN
TERMINAL beta
Version: 0.1
Timestamp: 1708841027.769181
Options
100220.KS
52.83%
1809.TW
51.88%
006220.KS
49.51%
0756.HK
49.35%
B7J.DE
48.43%
0T8B.F
-39.43%
009310.KS
-40.63%
SZGPF
-42.69%
GOLL4.SA
-52.40%
HGEN.L
-53.60%
AAPL $182.88 -0.81%
AMD $176.41 -3.00%
AMZN $174.58 0.00%
BRK-B $417.87 0.65%
GOOG $145.44 0.08%
IBM $185.76 0.84%
INTC $43.28 0.71%
JNJ $161.87 0.89%
JPM $184.12 0.57%
META $488.06 0.40%
MSFT $410.31 -0.33%
O $53.27 0.85%
TSLA $195.04 -1.20%
WMT $176.24 0.47%
QQQ $436.78 -0.2945%
TLT $93.87 1.3387%
VUSA.DE $89.31 0.4025%
VUAA.DE $88.65 0.3918%
FJPR.L $5.64 1.5565%
VWRP.L $97.83 0.1638%
VWRL.L $98.54 0.1626%
EMGU.L $3.60 -0.1111%
RDVY $52.42 0.3446%
FLOT $50.98 0.0000%
SCHZ $45.74 0.4171%
IBB $138.19 0.7436%
C020.DE $21.34 0.0000%
DFAX $24.72 0.0810%
LYP6.DE $226.20 0.4440%
MEUD.PA $226.19 0.4173%
IDWR.L $71.10 0.4521%
IQQW.DE $65.72 0.3972%
EXS1.DE $145.70 0.2477%
XESC.L $6865.00 0.1240%
DFAU $35.25 0.0852%
ACWV $104.02 0.2602%
VHYD.L $63.92 0.2746%
VGWD.DE $59.24 0.5602%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
RGEN
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
RGEN
Latest Performance
RGEN$197.72
$4.33 • 2.24%
RGEN
Price 197.72
Change Pct 2.24
Change Abs 4.33
Market Cap 11.0 billion
Eps 0.73
Pe Ratio 270.86
Outstanding Shares 55.8 million
Volume 132394
Avg Volume 618344
Industry Medical Instruments & Supplies
Sector Name Health Care
Country Short Name US
Announcement Earnings 2024-04-30 12:30:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
RGEN

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics;